Immunovant shifts primary focus to IMVT-1402, a next-generation anti-FcRn, targeting Graves' Disease with potential ...
A male in his 50s presented to the renal department with a diagnostic challenge of an unexplained kidney injury.
Steffini Stalos, DO, FCAP, is a pathology and lab medicine physician. She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Mean corpuscular hemoglobin concentration ...